[ad_1]
NEW YORK, March 17, 2019 / PRNewswire / – Investor Rights Law Firm Rosen Law Firm Reminds Purchasers of Diplomat Pharmacy, Inc. (NYSE: DPLO) Securities February 26, 2018 through February 21, 2019, inclusive (the "clbad period") of the April 25, 2019 applicant's main delay in the clbad action. The lawsuit seeks damages for diplomatic investors under federal securities laws.
To join the Diplomat clbad action, go to https://www.rosenlegal.com/cases-register-1515.html or call Phillip Kim, Esq. or Zachary Halper, Esq. toll-free at 866-767-3653 or by email at [email protected] or [email protected] for more clbad action information.
NO CATEGORY HAS BEEN CERTIFIED IN THE ACTION ABOVE. UNTIL A CATEGORY IS CERTIFIED, YOU ARE NOT REPRESENTED BY AN ADVICE UNLESS YOU KEEP IT. YOU CAN KEEP A CONSIDERATION OF YOUR CHOICE. YOU MAY ALSO REMAIN A MEMBER OF THE ABSENT CLASS AND DO NOTHING AT THIS POINT. THE CAPACITY OF AN INVESTOR TO SHARE IN A POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT ON THE FUNCTIONING OF PLAINTIFF.
According to the prosecution, the defendants made false and / or misleading statements and / or failed to disclose the following: (1) Diplomat had downplayed its success in integrating and growing its content management business company, which included LDI Integrated and National Pharmaceutical, two companies acquired by Diplomat in late 2017; (2) Therefore, Diplomat would need to record a non-cash impairment charge of approximately $ 630 million relating to its PBM business and these acquisitions in 2017; (3) In view of the above, Diplomat would withdraw its preliminary forecast for the year 2019 published less than seven weeks ago; and (4) consequently, the statements of the accused regarding Diplomat's activities, operations and prospects were materially false and misleading and / or lacked a reasonable basis at all relevant times. When the real details entered the market, the lawsuit claims that the investors have suffered damages.
A clbad action has already been filed. If you wish to serve as principal applicant, you must move the Court by the April 25, 2019. A principal applicant is a representative party acting on behalf of the other clbad members in the direction of the dispute. If you wish to join the litigation, please go to https://www.rosenlegal.com/cases-register-1515.html or to discuss your rights or interests in this clbad action, please contact Phillip Kim or Zachary Halper Rosen Law Firm toll-free at 866-767-3653 or by email at [email protected] or [email protected].
Follow us for LinkedIn updates: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Rosen's law firm represents investors from around the world and focuses its practice on clbad actions in securities and derivative litigation by shareholders. Rosen's law firm has been ranked # 1 by ISS Securities Clbad Action Services for the number of clbad action lawsuits filed in 2017. The firm has been in the top 3 every year since 2013.
Contact information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
Zachary Halper, Esq.
The law firm Rosen, P.A.
275 Madison Avenue, 34th Ground
New York, NY 10016
Tel .: (212) 686-1060
Toll free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com
SOURCE Rosen Law Firm, P.A.
Related Links
http://www.rosenlegal.com
[ad_2]
Source link
